
Slide Shows
about 11 hours ago
10 ways AI is creeping into medical care6 days ago
The 10 least vaccinated states in 20266 days ago
The 10 most vaccinated states in 2026Latest News

10 ways AI is creeping into medical care

Medicare's new drug pricing plan could backfire, driving up prices worldwide, study warns

What is old is new again with childhood vaccines, unfortunately

Saving America's primary care system requires bold action now

How does Public Service Loan Forgiveness work, and who still qualifies?
Shorts










Medical Device and Technology
Latest Videos
Medical Economics Digital Edition










All News


Independent primary care is struggling under a payment system stacked against it

The CBO projects about 5.2 million adults will drop off Medicaid under the new rules that begin Jan. 1. Medical Economics spoke with Pear Suite co-founder and CEO Colby Takeda about the CHW workforce states are leaning on to reach them.

Checks are due to start in October, and the administration has not said how it arrived at $500 or which years the disputed fees cover.

A JAMA Network Open qualitative study of 22 physicians finds leave policies and leadership sensitivity shape whether doctors successfully return to clinical practice after serious illness

New national research shows health systems and health plans still can't get provider data right — and the fallout lands squarely on physician practices

Kansas court records reviewed by The New York Times show the practice charged 18% annual interest, garnished bank accounts and pursued arrest warrants over balances as small as $101.

The Pay PCPs Act of 2026 would blend prospective per-patient payments with fee-for-service, halve beneficiary cost sharing for primary care and exempt participating physicians from MIPS.

A review of eight leading virtual chronic kidney disease management solutions found minimal cost savings and no clear evidence of slowed disease progression, according to the Peterson Health Technology Institute.

Rigid adherence thresholds in CMS's updated coverage decision leave doctors and suppliers guessing — and vulnerable patients at risk of losing a life-extending therapy



























